Rockwell Medical (RMTI) Tops Q2 EPS by 9c, provides guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $0.67 --0%
Revenue Growth %: +10.8%
Financial Fact:
Cost of Sales: 11.23M
Today's EPS Names:
CRWS, MEI, PODC, More
Revenue Growth %: +10.8%
Financial Fact:
Cost of Sales: 11.23M
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q2 EPS of $0.05, $0.09 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $25.83 million versus the consensus estimate of $22.91 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $95-98 million, versus the consensus of $92.493 million.
Adjusted EBITDA: $0.75 to $1.5 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
